One pundit tracking the company is particularly concerned about the performance of its foundational snacks business.

A significant shareholding is being unloaded to the public.

The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

If management's predictions are accurate, the company is in for a period of sustained growth.

Usually, the Federal Open Market Committee makes decisions on adjusting its federal funds rate in unison. But not this time.

Nvidia has built a solid position for itself in this fast-growing data center niche that could help generate sizable revenue ...

New York Community Bancorp isn't realistically poised for sudden and dramatic improvement. The bank expanded too quickly in ...

Intel stock closed up 3.3% on the news, after jumping as much as 9.5% when the story first broke. Qualcomm closed down 2.9% ...

Many or all of the products here are from our partners that compensate us. It’s how we make money. But our editorial integrity ensures our experts’ opinions aren’t influenced by compensation. Terms ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

UiPath has struggled this year as its growth rate has been slowing down and it's nowhere near posting a profit. The consensus ...

Yet its foundry business has shown potential for improvement. Intel will turn that business into a separate subsidiary, ...